ArticleAesthetic plastic surgery2025
Regenerative
Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The evolving landscape of eyebrow reconstruction: from traditional flaps to minimally invasive techniques and regenerative medicine.Frontiers in surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUsing stem cells for hair restoration (reversal of hair loss, regeneration of hair follicles) is already a well-established clinical practice.
objectiveTo present regenerative hair transplantation, a pioneering and innovative technique that combines traditional hair transplantation and autologous stem cells to promote hair growth, and improve transplantation results, increasing hair density, hair quality, and graft success rate.
methodsFollicular stem cells were obtained in hair transplantation using the regenerative hair transplantation method. After being extracted, the follicles underwent dissection and filtration, and the cell solution obtained was injected into the transplant recipient area, where there was the presence of native follicles.
resultsOur analysis revealed a high percentage of cells marked with CD44. The combined analysis (cell type and quantity) indicated that most cells had a phenotypic profile characteristic of dermal papilla MSCs. DISCUSSION/
conclusionThe combination of hair transplantation with the use of autologous mesenchymal cells represents a promising advance in treating baldness. This technique allows the optimization of transplantation results, providing greater hair density. This is because the method combines the clinical treatment of native follicles with autologous cells and the hair transplant. This method is innovative because, to date, there has been no description of this combination in the literature. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
40676309What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.